The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 19, 2015

Filed:

Dec. 17, 2010
Applicants:

Jingyan Han, Beijing, CN;

Jun Guo, Beijing, CN;

Jiying Yang, Beijing, CN;

Yu Zhang, Beijing, CN;

Mingxia Wang, Beijing, CN;

Yuying Liu, Beijing, CN;

Inventors:

Jingyan Han, Beijing, CN;

Jun Guo, Beijing, CN;

Jiying Yang, Beijing, CN;

Yu Zhang, Beijing, CN;

Mingxia Wang, Beijing, CN;

Yuying Liu, Beijing, CN;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 36/25 (2006.01); A61K 36/00 (2006.01); A61K 36/537 (2006.01); A61K 36/258 (2006.01); A61K 9/46 (2006.01); A61K 9/00 (2006.01); A61K 9/16 (2006.01); A61K 9/19 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01);
U.S. Cl.
CPC ...
A61K 36/258 (2013.01); A61K 9/0007 (2013.01); A61K 9/0019 (2013.01); A61K 9/0056 (2013.01); A61K 9/1623 (2013.01); A61K 9/1652 (2013.01); A61K 9/19 (2013.01); A61K 9/2027 (2013.01); A61K 9/2031 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 9/4858 (2013.01);
Abstract

The present invention discloses a traditional Chinese drug consisting of Danshen extract and Sanqi extract, the pharmaceutical composition comprising the above traditional Chinese drug as an active component and the use thereof. The traditional Chinese drug consists of Danshen extract and Sanqi extract in a weight ratio of (2˜6):(0.5˜2). The invention further discloses the effect of the above traditional Chinese drug and the pharmaceutical composition comprising the above traditional Chinese drug as an active component for treating cardiac microcirculation disorder and myocardial damage induced by ischemia/reperfusion.


Find Patent Forward Citations

Loading…